» Articles » PMID: 37484815

AI Models for Protein Design Are Driving Antibody Engineering

Overview
Date 2023 Jul 24
PMID 37484815
Authors
Affiliations
Soon will be listed here.
Abstract

Therapeutic antibody engineering seeks to identify antibody sequences with specific binding to a target and optimized drug-like properties. When guided by deep learning, antibody generation methods can draw on prior knowledge and experimental efforts to improve this process. By leveraging the increasing quantity and quality of predicted structures of antibodies and target antigens, powerful structure-based generative models are emerging. In this review, we tie the advancements in deep learning-based protein structure prediction and design to the study of antibody therapeutics.

Citing Articles

What does AlphaFold3 learn about antigen and nanobody docking, and what remains unsolved?.

Hitawala F, Gray J bioRxiv. 2025; .

PMID: 39975279 PMC: 11838198. DOI: 10.1101/2024.09.21.614257.


ProteinReDiff: Complex-based ligand-binding proteins redesign by equivariant diffusion-based generative models.

Nguyen V, Nguyen N, Hy T Struct Dyn. 2024; 11(6):064102.

PMID: 39629167 PMC: 11614476. DOI: 10.1063/4.0000271.


ABodyBuilder3: improved and scalable antibody structure predictions.

Kenlay H, Dreyer F, Cutting D, Nissley D, Deane C Bioinformatics. 2024; 40(10).

PMID: 39363504 PMC: 11474105. DOI: 10.1093/bioinformatics/btae576.


AI-driven antibody design with generative diffusion models: current insights and future directions.

He X, Li J, Xu J, Shan H, Shen S, Gao S Acta Pharmacol Sin. 2024; 46(3):565-574.

PMID: 39349764 PMC: 11845702. DOI: 10.1038/s41401-024-01380-y.


A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation.

Tang X, Dai H, Knight E, Wu F, Li Y, Li T Brief Bioinform. 2024; 25(4).

PMID: 39007594 PMC: 11247410. DOI: 10.1093/bib/bbae338.


References
1.
Leem J, Mitchell L, Farmery J, Barton J, Galson J . Deciphering the language of antibodies using self-supervised learning. Patterns (N Y). 2022; 3(7):100513. PMC: 9278498. DOI: 10.1016/j.patter.2022.100513. View

2.
Anand N, Eguchi R, Mathews I, Perez C, Derry A, Altman R . Protein sequence design with a learned potential. Nat Commun. 2022; 13(1):746. PMC: 8826426. DOI: 10.1038/s41467-022-28313-9. View

3.
Ruffolo J, Sulam J, Gray J . Antibody structure prediction using interpretable deep learning. Patterns (N Y). 2022; 3(2):100406. PMC: 8848015. DOI: 10.1016/j.patter.2021.100406. View

4.
Mahajan S, Ruffolo J, Frick R, Gray J . Hallucinating structure-conditioned antibody libraries for target-specific binders. Front Immunol. 2022; 13:999034. PMC: 9635398. DOI: 10.3389/fimmu.2022.999034. View

5.
Nijkamp E, Ruffolo J, Weinstein E, Naik N, Madani A . ProGen2: Exploring the boundaries of protein language models. Cell Syst. 2023; 14(11):968-978.e3. DOI: 10.1016/j.cels.2023.10.002. View